相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine
Jan Gleichenhagen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study
Renate Pichler et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
UBC® Rapid Test for detection of carcinoma in situ for bladder cancer
Thorsten H. Ecke et al.
TUMOR BIOLOGY (2017)
Evaluation of the diagnostic accuracy of UBC® Rapid in bladder cancer: a Swedish multicentre study
Johan Styrke et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2017)
Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2015)
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
Faysal A. Yafi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2014)
Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer
Rene Ritter et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Molecular markers for urothelial bladder cancer prognosis: Toward implementation in clinical practice
Bas W. G. van Rhijn et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study
Severine Banek et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity
Ashish M. Kamat et al.
BJU INTERNATIONAL (2011)
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2011)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2010)
Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features
Kurt B. Hodges et al.
HUMAN PATHOLOGY (2010)
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection
Yair Lotan et al.
BJU INTERNATIONAL (2009)
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
M. Craig Hall et al.
JOURNAL OF UROLOGY (2007)
Bladder tumor markers beyond cytology:: International consensus panel on bladder tumor markers
VB Lokeshwar et al.
UROLOGY (2005)
Urine markers for bladder cancer surveillance: A systematic review
BWG van Rhijn et al.
EUROPEAN UROLOGY (2005)
The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine
S Siracusano et al.
EUROPEAN UROLOGY (2005)
Risk stratification for bladdertumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology
SF Shariat et al.
EUROPEAN UROLOGY (2004)
A side by side comparison of cytology and biomarkers for bladder cancer detection
GL Schroeder et al.
JOURNAL OF UROLOGY (2004)
Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma
OW Hakenberg et al.
UROLOGY (2004)
Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses
Y Lotan et al.
UROLOGY (2003)
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: A comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests
MG Friedrich et al.
JOURNAL OF UROLOGY (2002)
Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBCIRMA) as markers for transitional cell carcinoma of the bladder
M Babjuk et al.
EUROPEAN UROLOGY (2002)
Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis
MP Raitanen et al.
EUROPEAN UROLOGY (2002)
Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder
C Mian et al.
UROLOGY (2000)
分享论文
